Elisa F Long

Summary

Affiliation: Yale University
Country: USA

Publications

  1. pmc Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis
    Elisa F Long
    Yale School of Management, 135 Prospect Street, New Haven, CT, 06520, USA
    J Gen Intern Med 28:1294-301. 2013
  2. pmc HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis
    Elisa F Long
    School of Management, Yale University, New Haven, Connecticut, United States of America
    PLoS ONE 6:e27625. 2011
  3. pmc Potential population health outcomes and expenditures of HIV vaccination strategies in the United States
    Elisa F Long
    School of Management, Yale University, New Haven, CT, United States
    Vaccine 27:5402-10. 2009
  4. pmc The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States
    Elisa F Long
    Yale School of Management, New Haven, Connecticut 06520, USA
    Ann Intern Med 153:778-89. 2010
  5. pmc The cost-effectiveness of a modestly effective HIV vaccine in the United States
    Elisa F Long
    School of Management, Yale University, 135 Prospect Street, New Haven, CT 06520, USA
    Vaccine 29:6113-24. 2011

Detail Information

Publications5

  1. pmc Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis
    Elisa F Long
    Yale School of Management, 135 Prospect Street, New Haven, CT, 06520, USA
    J Gen Intern Med 28:1294-301. 2013
    ....
  2. pmc HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis
    Elisa F Long
    School of Management, Yale University, New Haven, Connecticut, United States of America
    PLoS ONE 6:e27625. 2011
    ..It unknown whether the health benefits and costs of routine nucleic acid amplification testing (NAAT) are justified, given the availability of newer fourth-generation immunoassay tests...
  3. pmc Potential population health outcomes and expenditures of HIV vaccination strategies in the United States
    Elisa F Long
    School of Management, Yale University, New Haven, CT, United States
    Vaccine 27:5402-10. 2009
    ..Universal vaccination is cost-effective for vaccines with 50% efficacy and price similar to other infectious disease vaccines...
  4. pmc The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States
    Elisa F Long
    Yale School of Management, New Haven, Connecticut 06520, USA
    Ann Intern Med 153:778-89. 2010
    ..Although recent guidelines call for expanded routine screening for HIV, resources for antiretroviral therapy (ART) are limited, and all eligible persons are not currently receiving treatment...
  5. pmc The cost-effectiveness of a modestly effective HIV vaccine in the United States
    Elisa F Long
    School of Management, Yale University, 135 Prospect Street, New Haven, CT 06520, USA
    Vaccine 29:6113-24. 2011
    ..5 years. Estimating the potential health benefits associated with a one-time vaccination campaign, as well as the projected benefits of repeat booster vaccination, may inform future HIV vaccine research and licensing decisions...